Loading...
Share this Job
Apply now »

 

Let's push the boundaries together and make the most of your talents!

Payer Value Strategy Lead for Bimekizumab

Location: 

Anderlecht, Brussels, Belgium

Job Function:  Market Access & Pricing
Job ID:  66022

Payer Value Strategy lead

 

UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries in science and solution development. With us, our talents make the most of who they are, unlocking innovation and setting new standards for patients.

 

Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” To find the answers, we connect with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.

 

UCB is structured into Patient Value Units (PVUs) responsible for driving asset strategy and execution by main therapy areas (Bone, Immunology and Neurology), and Center of Excellences which are responsible for scouting the future and providing cutting edge expertise and methodologies for the PVUs to help them maximize their impact while supporting them on their execution to create patient value.

 

Global Patient Access (GPA) is one of such Center of Excellence, developing and co-creating Patient Access strategy and execution activities for new products across their life cycle. GPA members work cross-functionally with members of PVUs, Real World Evidence (RWE) teams, Regulatory, Clinical, etc.

 

UCB is currently seeking a Patient Access Strategy Lead to support the commercialization of new assets in different PVUS. Final project/asset allocation will be driven by business needs. The candidate will report into the GPA in the Payer Value & Health Economics Strategy team.

 

The Patient Access Strategy Lead will work closely and in collaboration with the PVUs Access Strategy lead, the Health Economics and Global Pricing team and the Access teams of major geographies (US, EU5, China, Japan).

 

The Payer Value Strategy lead will focus on:

 

Preparation of payer value strategy and value proposition

Follows the principles of UCB’s patient value framework (AXIA) to quantify asset’s patient value in coordination with Health Economics and Global Pricing teams.

  • Represents payer needs in cross-functional team activities including clinical development, regulatory, commercial and planning processes such as Target Patient Value Profile (TPVP) development, communications and medical affairs/HCP engagement, payer education/ disease awareness, 10 year planning, and patient value brand plan (budget plan)
  • Ensures that the clinical evidence generation plan from Ph2 through RWE/post-marketing is optimized for payer value strategy. This is accomplished in collaboration with Health Economics, Outcomes Research and Patient-Reported Outcomes colleagues.
  • Evaluates a broad range of evidence types for their value in contributing to an impactful value story (i.e. patient preference, qualitative research, RWE beyond the obvious), ensures effective utilization of the totality of available evidence in a timely manner for maximum impact.
  • Listens and collects actionable insights in a systematic way from key (payer) stakeholders, decision makers, competitors, market trends and news shared by UCB affiliates to shape the value proposition and access strategy.
  • Seeks input and alignment with key internal stakeholders, including major geographies, PVUs Access Strategy Lead, Real World Evidence Team, etc.

 

Development of payer value strategy and value proposition

 

  • Co-develops the expanded payer value proposition of the asset in selected indications taking into account the traditional clinical differentiation, safety profile, economic value and new value drivers (patient experience, social/legal/caregiver aspects) as well as the additional ‘beyond-the-drug’ offerings UCB might develop to support patients and the system to overcome identified break points through the patient/treatment journey.
  • Co-develops the asset’s access strategy which maximizes the impact of the value proposition tailored for payer archetypes with specific focus on major geographic needs (EU5, US, Japan, China).
  • The strategy should be aligned with the broader UCB portfolio strategy
  • Champions the payer value strategy with internal stakeholders (Market-Facing Team, Development Team, HEOR colleagues, PRO colleagues, RWE colleagues).
  • Collaborates with the Publications Lead and Access Lead to ensure that payer needs for publications are met and that publications in the plan are optimized for payers.

 

Bring outside in

  • Leads efforts to ensure payer input and external validation of critical assumptions and plans associated with payer strategy for successful HTA negotiations
  • Leads activities to externally and internally validate and critique clinical development program and Payer Value Strategy plans, using multiple approaches (advisory boards, market research, ad hoc interactions) to maximize the asset strategy and available data-set by launch
  • Develops collaborations with payers, policy makers and consultants to improve UCB’s Payer value strategies and plans
  • Collaborates with major geographies in pre-approval interactions with payers and making connections to the broader development team for effective, efficient and insightful early advice meetings
  • Builds on learnings across PVUs and assets. Considers ways in which past or ongoing activities and non-drug solutions could be leveraged.
     

 Development of core global value materials

  • Delivers payer value story related global materials including global value dossier, value proposition slide deck, access strategy implementation guide, Q&A/objection handler, video/podcast presentations, and other customer-facing materials for payers. It is important to be critical and innovative on how these materials can be improved further to meet UCB affiliates’ and payers’ needs.
  • Develops negotiation strategy based on patient value, including outcomes-based / innovative agreements, financing models where these can bring value
     

 Supports local implementation of global access strategy

  • Excellence in launch execution: leads knowledge transfer of strategy and tactics from global to affiliates and supports effective preparation and implementation of access strategies in major geographies (as per UCB’s pricing and reimbursement submission guidance)
  • Develops and implements value story and access strategy related trainings such as launch readiness, launch implementation trainings, payer MOCK sessions for local access teams.
     

Incumbent profile:

 

Education

  • Bachelor’s degree in a relevant life sciences or business-related discipline
  • Specific qualifications such as Health Economics, HTA, or Public Health, Masters or PhD (optional, but preferred)

 
Experience

  • Minimum 5 years of experience in market access related functions in the biopharmaceutical industry or consulting. Ideally, the successful candidate could have experience with health economics, outcomes research, or health technology assessment.
  • At least 3 (ideally 5) years of experience in the development of access strategy and/or payer evidence
  • Knowledge of both US and EU payer/HTA ecosystems preferred along with other key international markets.  
  • Proven track record in the design and implementation of global access strategies, payer and HTA submissions/interactions and/or payer insights generation 
  • Experience in pre-launch and launch activities
  • Demonstration of successful working relationships with external stakeholders
  • Therapeutic area experience in UCB’s key areas (Neurology/Immunology) preferred
     

 Required Skills - General

  • Excellent interpersonal and leadership skills
  • Payer access strategy excellence with knowledge of key approaches, critical steps
  • Technical ability to lead and deliver projects relevant to the functional objectives
  • Strong understanding of needs of payers and strategies for success in market access
  • Strong project planning and management skills
  • Excellent communication skills with individuals with different cultural, professional and academic backgrounds, including the ability to simplify complex issues
  • Builds actively on long-term relationships, both internally and externally across different functions
  • Strategic thinking, problem-solving ability, customer focus, and commitment to quality

 

Specific Skills / Behaviors

  • Team player, collaborative balanced with a bias for fast decision making
  • Proactive & results driven
  • Positive, can-do attitude
  • Self-confident, good at influencing
  • Scientifically inquisitive
  • Ability to lead cross-functional meetings and projects across matrix and geographies
  • Excellent command of written and spoken English
  • Strong understanding of principles of good scientific and commercial communication and clear messaging to enable ease of understanding by target audiences
  • Enjoys working in cross-functional, matrix environment, being energized by co-developing strategies and materials within team, endures ambiguity, frequent changes in team set-up and organizational surrounding
     
    Location: UCB US office in Altana, Georgia;  UCB HQ, Brussels Belgium (preferred) or UCB UK (Slough)

 


Job Segment: Neurology, Immunology, Medical, Law, Consulting, Healthcare, Legal, Technology

Apply now »